Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged misrepresentation of financial data and inadequate insurance coverage, impacting investors who acquired shares during the specified class period [6]. Group 1: Allegations - The lawsuit claims that Ardent Health reported inflated accounts receivable and delayed recognizing losses on uncollectable accounts during the class period from July 18, 2024, to November 12, 2025 [6]. - It is alleged that the company did not maintain sufficient professional malpractice liability insurance to cover potential claims arising from its operations [6]. Group 2: Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised assessments of accounts receivable collectability, which followed a transition to a new revenue accounting system [6]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, a decline of nearly 34%, from $14.05 per share to $9.30 per share on November 13, 2025 [6]. Group 3: Legal Process - Investors who purchased Ardent Health securities during the class period have until March 9, 2026, to apply to the Court to be appointed as lead plaintiff in the lawsuit [6].
ARDENT HEALTH URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights